Global Cell Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cell Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Cell Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Therapy market is projected to reach US$ 250460 million in 2034, increasing from US$ 101000 million in 2022, with the CAGR of 13.5% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.
Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.
North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Segment by Type
Stem Cell
Non-Stem Cell
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cell Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cell Therapy introduction, etc. Cell Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Cell Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Cell Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Therapy market is projected to reach US$ 250460 million in 2034, increasing from US$ 101000 million in 2022, with the CAGR of 13.5% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.
Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.
North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Segment by Type
Stem Cell
Non-Stem Cell
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cell Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cell Therapy introduction, etc. Cell Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Cell Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.